3,4-Methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition-Reference-Cited by-同舟云学术

3,4-Methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition

Published:2011-05 Issue:1 Volume:203 Page:82-91
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Antolino-Lobo Irene,Meulenbelt Jan,Nijmeijer Sandra M.,Maas-Bakker Roel F.,Meijerman Irma,van den Berg Martin,van Duursen Majorie B.M.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference43 articles.

1. Ecstasy: a common cause of severe acute hepatotoxicity;Andreu;J. Hepatol.,1998

2. Differential roles of phase I and phase II enzymes in 3,4-methylendioxymethamphetamine-induced cytotoxicity;Antolino-Lobo;Drug Metab. Dispos.,2010

3. Species differences in mechanism-based inactivation of CYP3A in humans, rats and mice;Aueviriyavit;Drug Metab. Pharmacokinet.,2010

4. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction;Bertilsson;Proc. Natl. Acad. Sci. U.S.A.,1998

5. SXR, a novel steroid and xenobiotic-sensing nuclear receptor;Blumberg;Genes Dev.,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study the effect of 3,4-Methylenedioxy methamphetamine on cytochrome P450 2E1 activity;Brazilian Journal of Pharmaceutical Sciences;2022

2. Adverse pharmacokinetic interactions between illicit substances and clinical drugs;Drug Metabolism Reviews;2019-12-11

3. Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences;Biochemical Journal;2017-10-10

4. Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model;DARU Journal of Pharmaceutical Sciences;2017-06-28

5. Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells;Xenobiotica;2015-09-04